These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Botulinum toxin A treatment of overactive corrugator supercilii in thyroid eye disease. Olver JM Br J Ophthalmol; 1998 May; 82(5):528-33. PubMed ID: 9713061 [TBL] [Abstract][Full Text] [Related]
3. A prospective evaluation of the efficacy of topical adhesive pads for the reduction of facial rhytids. Ryan WR; Most SP Arch Facial Plast Surg; 2009; 11(4):252-6. PubMed ID: 19620531 [TBL] [Abstract][Full Text] [Related]
4. Prospective, double-blind, randomized, parallel-group, dose-ranging study of botulinum toxin type A in men with glabellar rhytids. Carruthers A; Carruthers J Dermatol Surg; 2005 Oct; 31(10):1297-303. PubMed ID: 16188182 [TBL] [Abstract][Full Text] [Related]
5. Customized Orbital Decompression Surgery Combined with Eyelid Surgery or Strabismus Surgery in Mild to Moderate Thyroid-associated Ophthalmopathy. Choi SW; Lee JY; Lew H Korean J Ophthalmol; 2016 Feb; 30(1):1-9. PubMed ID: 26865797 [TBL] [Abstract][Full Text] [Related]
6. The transconjunctival approach with lateral canthal extension for three-wall orbital decompression in thyroid orbitopathy. Barkhuysen R; Nielsen CC; Klevering BJ; Van Damme PA J Craniomaxillofac Surg; 2009 Apr; 37(3):127-31. PubMed ID: 19056289 [TBL] [Abstract][Full Text] [Related]
7. Graded orbital decompression based on severity of proptosis. Kikkawa DO; Pornpanich K; Cruz RC; Levi L; Granet DB Ophthalmology; 2002 Jul; 109(7):1219-24. PubMed ID: 12093642 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of fresh versus refrigerated botulinum toxin in the treatment of lateral periorbital rhytids. Hui JI; Lee WW Ophthalmic Plast Reconstr Surg; 2007; 23(6):433-8. PubMed ID: 18030112 [TBL] [Abstract][Full Text] [Related]
10. The Pro 12 Ala PPAR gamma gene polymorphism: possible modifier of the activity and severity of thyroid-associated orbitopathy (TAO). Alevizaki M; Mantzou E; Cimponeriu A; Saltiki K; Philippou G; Wiersinga W Clin Endocrinol (Oxf); 2009 Mar; 70(3):464-8. PubMed ID: 18624999 [TBL] [Abstract][Full Text] [Related]
11. Balanced (endoscopic medial and transcutaneous lateral) orbital decompression in Graves' orbitopathy. Hernández-García E; San-Román JJ; González R; Nogueira A; Genol I; Stoica B; Toledano N; Plaza G Acta Otolaryngol; 2017 Nov; 137(11):1183-1187. PubMed ID: 28741406 [TBL] [Abstract][Full Text] [Related]
12. Epidemiology and Clinical Features of Thyroid-associated Orbitopathy in Accra. Ackuaku-Dogbe EM; Akpalu J; Abaidoo B Middle East Afr J Ophthalmol; 2017; 24(4):183-189. PubMed ID: 29422752 [TBL] [Abstract][Full Text] [Related]
14. The prevalence and implications of ocular hypertension and glaucoma in thyroid-associated orbitopathy. Cockerham KP; Pal C; Jani B; Wolter A; Kennerdell JS Ophthalmology; 1997 Jun; 104(6):914-7. PubMed ID: 9186429 [TBL] [Abstract][Full Text] [Related]
15. Fixation duress in the pathogenesis of upper eyelid retraction in thyroid orbitopathy. A prospective study. Hamed LM; Lessner AM Ophthalmology; 1994 Sep; 101(9):1608-13. PubMed ID: 8090464 [TBL] [Abstract][Full Text] [Related]
18. Current Understanding of the Progression and Management of Thyroid Associated Orbitopathy: A Systematic Review. Hodgson NM; Rajaii F Ophthalmol Ther; 2020 Mar; 9(1):21-33. PubMed ID: 31823232 [TBL] [Abstract][Full Text] [Related]
19. The incidence of diplopia following coronal and translid orbital decompression in Graves' orbitopathy. Paridaens D; Hans K; van Buitenen S; Mourits MP Eye (Lond); 1998; 12 ( Pt 5)():800-5. PubMed ID: 10070513 [TBL] [Abstract][Full Text] [Related]
20. [Modified orbital decompression for severe thyroid associated ophthalmopathy]. Wang Y; Xiao LH; Yang ZK; Li YY Zhonghua Yan Ke Za Zhi; 2013 Mar; 49(3):242-9. PubMed ID: 23866706 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]